Bidness Etc - Tekmira Experiences A Decrease In Share Value

The biotech company goes through a difficult financial time as its share price drops.

Tekmira Pharmaceutical Corp has been in the recent news as the medicine making company has been seen a very negative dip since the last trading session that it went through. The company has experienced a drop of 0.97% in the share price in the most recent trade that it carried out on the stock index. In the first week of April, the drop in share price has been recorded up to 1% whereas the decrease recorded for the previous four weeks has come around to a massive 7.25%. The analysts covering the stock of the biotech company have recorded that a spark of negative trading has been recorded on the S&P 500 in the most recent trading week that the company has faced which shows a loss of 1.25%.

As for the stock index, the bio company has been observed to be working under bearish energy as it has been reported that Tekmira Pharmaceutical has been going downwards for quite some time on the S&P 500 and the loss has come around to 7.06% if the previous month is also taken into consideration. Analysts that are covering the stock of the company have given guidance to the investors and shareholders by giving them a signal of caution as to how they should be carrying out a further trade with the company.

In the most recent Tekmira Pharmaceutical news, it was seen that after quite a hyped up session in which the share price observed a fluctuating pace, by the end of the trade a massive decrease was witnessed by the bio firm. The loss by which the shares dropped came about at 0.85%. After the points on the stock index saw a dip by 0.15 points, the price of the shares managed to reach a feeble $17.4 after which the company wrapped up the trade.

The shares of Tekmira Pharmaceutical opened at a price of $17.5 at the start of the trading day in which the highest point that the company reached came around at $17.65 and the lowest that the firm reached throughout the day came about at $17.02. Before that, the previous session of the medicine making firm closed at a price of $17.55. The shares that were traded during the fast paced and amusing trade on the stock index were recorded to have a volume of 559,840. The 52 week high price that the company currently holds on the stock index has come around at $29.93.